Interaction of DNA-intercalating antitumor agents with adrenoceptors.

Abstract:

:The interaction between some examples of mononuclear and binuclear DNA-intercalating antitumor agents and alpha- and beta-adrenoceptors has been studied using radioligand-binding assays. Competition for 125I-BE 2254, [3H]rauwolscine, and (-)-[3H]dihydroalprenolol binding was used to assess affinity for alpha 1-, alpha 2-, and beta-adrenoceptor-binding sites, respectively. Two homologous series of alkyl-linked diacridines and diquinolines were found to interact poorly with beta-adrenoceptors, with only the largest members having appreciable affinity. By contrast, these compounds bind strongly and in a complex manner to alpha 1- and alpha 2-adrenoceptors. The affinity of diacridines for both alpha-adrenoceptor classes has a parabolic dependence on alkyl chain length with the hexyl and pentyl derivatives being the most potent at the alpha 1- (Ki = 11.5 +/- 2.3 nM) and alpha 2- (Ki = 143 +/- 26 nM) binding sites, respectively. The dependence of inhibition constants on linker chain length for the diquinolines is more complicated, with the ethyl- and heptyl-linked dimers having the greatest affinity for each alpha subclass. There is a nadir in affinity for the pentyl and butyl ligands and an increase in dissociation constant for octyl and longer homologues. Thus, the ethyl diquinoline has Ki values of 6.6 +/- 1.2 and 110 +/- 14 nM for the alpha 1- and alpha 2- adrenoceptors, respectively, and, correspondingly, the heptyl derivative has values of 39 +/- 4 and 51 +/- 1 nM. These findings are discussed with respect to a model of the alpha-adrenoceptor in which the radioligand-binding site is situated in a trench or cleft, surrounded by a flat surface bounded by walls. Daunomycin was found to have no affinity for adrenoceptors of any type and mitoxantrone similarly fails to interact with alpha 2- and beta-adrenoceptors, but binds to the alpha 1 subclass with an inhibition constant (Ki) of 3930 +/- 420 nM. Bisantrene also has no affinity for beta-adrenoceptors but binds to alpha 1- and alpha 2- adrenoceptors with Ki values of 145 +/- 24 and 2310 +/- 430 nM, respectively. Among the mononuclear acridine drugs studied, only nitracrine shows detectable interaction with beta-adrenoceptors (Ki = 760 +/- 50 nM). This compound, like bisantrene, has high affinity for the alpha 1-adrenoceptor (Ki = 131 +/- 17 nM) and moderate affinity for the alpha 2 subclass (Ki = 2180 +/- 500 nM).(ABSTRACT TRUNCATED AT 400 WORDS)

journal_name

Mol Pharmacol

journal_title

Molecular pharmacology

authors

Adams A,Jarrott B,Elmes BC,Denny WA,Wakelin LP

subject

Has Abstract

pub_date

1985-04-01 00:00:00

pages

480-91

issue

4

eissn

0026-895X

issn

1521-0111

journal_volume

27

pub_type

杂志文章
  • Conformational dynamics of Kir3.1/Kir3.2 channel activation via δ-opioid receptors.

    abstract::This study assessed how conformational information encoded by ligand binding to δ-opioid receptors (DORs) is transmitted to Kir3.1/Kir3.2 channels. Human embryonic kidney 293 cells were transfected with bioluminescence resonance energy transfer (BRET) donor/acceptor pairs that allowed us to evaluate independently reci...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.112.081950

    authors: Richard-Lalonde M,Nagi K,Audet N,Sleno R,Amraei M,Hogue M,Balboni G,Schiller PW,Bouvier M,Hébert TE,Pineyro G

    更新日期:2013-02-01 00:00:00

  • The role of human equilibrative nucleoside transporter 1 on the cellular transport of the DNA methyltransferase inhibitors 5-azacytidine and CP-4200 in human leukemia cells.

    abstract::The nucleoside analog 5-azacytidine is an archetypical drug for epigenetic cancer therapy, and its clinical effectiveness has been demonstrated in the treatment of myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML). However, therapy resistance in patients with MDS/AML remains a challenging issue. Mem...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.113.086801

    authors: Hummel-Eisenbeiss J,Hascher A,Hals PA,Sandvold ML,Müller-Tidow C,Lyko F,Rius M

    更新日期:2013-09-01 00:00:00

  • Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of binding.

    abstract::Understanding the molecular basis of ligand binding to receptors provides insights useful for rational drug design. This work describes development of a new antagonist radioligand of the type 1 cholecystokinin receptor (CCK1R), (2-fluorophenyl)-2,3-dihydro-3-[(3-isoquinolinylcarbonyl)amino]-6-methoxy-2-oxo-l-H-indole-...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.114.095430

    authors: Dong M,Vattelana AM,Lam PC,Orry AJ,Abagyan R,Christopoulos A,Sexton PM,Haines DR,Miller LJ

    更新日期:2015-01-01 00:00:00

  • Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.

    abstract::In order to elucidate the key atoms and/or stereostructures necessary for the inhibitory emergence of aldose reductase, crystal structure determinations were carried out for 11 oxazolecarbamate analogues, which have similar chemical and physicochemical properties but different inhibitory activities. The molecular conf...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Ishida T,In Y,Ohishi H,Yamamoto D,Inoue M,Tanaka C,Ueno Y,Ohmomo Y,Kanda N,Tanaka A

    更新日期:1988-09-01 00:00:00

  • Interaction of [3H]orphanin FQ and 125I-Tyr14-orphanin FQ with the orphanin FQ receptor: kinetics and modulation by cations and guanine nucleotides.

    abstract::The heptadecapeptide orphanin FQ (OFQ) has been identified as the endogenous ligand for a G protein-coupled receptor (OFQ-R), which, despite its high degree of sequence similarity to opioid receptors, fails to bind opioid ligands. We developed two radioligands for the OFQ-R: a tritiated native OFQ peptide ([3H]OFQ) an...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.51.5.816

    authors: Ardati A,Henningsen RA,Higelin J,Reinscheid RK,Civelli O,Monsma FJ Jr

    更新日期:1997-05-01 00:00:00

  • Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation.

    abstract::Noscapine, a microtubule-interfering agent, has been shown to arrest mitosis, to induce apoptosis, and to have potent antitumor activity. We report herein that two brominated derivatives of noscapine, 5-bromonoscapine (5-Br-nosc) and reduced 5-bromonoscapine (Rd 5-Br-nosc), have higher tubulin binding activity than no...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.63.4.799

    authors: Zhou J,Gupta K,Aggarwal S,Aneja R,Chandra R,Panda D,Joshi HC

    更新日期:2003-04-01 00:00:00

  • Locating a plausible binding site for an open-channel blocker, GlyH-101, in the pore of the cystic fibrosis transmembrane conductance regulator.

    abstract::High-throughput screening has led to the identification of small-molecule blockers of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel, but the structural basis of blocker binding remains to be defined. We developed molecular models of the CFTR channel on the basis of homology to the bac...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.112.080267

    authors: Norimatsu Y,Ivetac A,Alexander C,O'Donnell N,Frye L,Sansom MS,Dawson DC

    更新日期:2012-12-01 00:00:00

  • Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate Cancer.

    abstract::The microtubule-binding taxanes, docetaxel and cabazitaxel, are administered intravenously for the treatment of castration-resistant prostate cancer (CRPC) as the oral administration of these drugs is largely hampered by their low and highly variable bioavailabilities. Using a simple, rapid, and environmentally friend...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.119.118539

    authors: Liao VWY,Kumari A,Narlawar R,Vignarajan S,Hibbs DE,Panda D,Groundwater PW

    更新日期:2020-06-01 00:00:00

  • Valproic acid inhibits angiogenesis in vitro and in vivo.

    abstract::Valproic acid (VPA) is a widely used antiepileptic agent that is undergoing clinical evaluation for anticancer therapy. We assessed the effects of VPA on angiogenesis in vitro and in vivo. In human umbilical vein endothelial cells, therapeutically relevant concentrations of VPA (0.25 to 1 mM) inhibited proliferation, ...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.65.3.520

    authors: Michaelis M,Michaelis UR,Fleming I,Suhan T,Cinatl J,Blaheta RA,Hoffmann K,Kotchetkov R,Busse R,Nau H,Cinatl J Jr

    更新日期:2004-03-01 00:00:00

  • Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.

    abstract::The effect of the neuromuscular blocker alcuronium on the binding of N-[3H]-methylscopolamine [( 3H]NMS) and l-[3H]quinuclidinylbenzilate ([3H]QNB) to muscarinic binding sites in rat heart atria, longitudinal smooth muscle of the ileum, cerebral cortex, cerebellum, and submaxillary glands was measured using filtration...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Tucek S,Musílková J,Nedoma J,Proska J,Shelkovnikov S,Vorlícek J

    更新日期:1990-11-01 00:00:00

  • Essential role of mitogen-activated protein kinase pathway and c-Jun induction in epidermal growth factor-induced gene expression of human 12-lipoxygenase.

    abstract::The role of mitogen-activated protein kinase signaling and the transcription factor c-Jun in epidermal growth factor (EGF)-induced expression of 12-lipoxygenase in human epidermoid carcinoma A431 cells was studied. EGF increased the activation of extracellular signal-regulated kinase (ERK) and c-Jun amino terminal kin...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Chen BK,Kung HC,Tsai TY,Chang WC

    更新日期:2000-01-01 00:00:00

  • Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors.

    abstract::The constitutive androstane receptor (CAR) regulates mouse and human CYP2B genes through binding to the direct repeat-4 (DR4) motifs present in the phenobarbital-responsive enhancer module (PBREM). The preference of PBREM elements for nuclear receptors and the extent of cross-talk between CAR and other nuclear recepto...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.62.2.366

    authors: Mäkinen J,Frank C,Jyrkkärinne J,Gynther J,Carlberg C,Honkakoski P

    更新日期:2002-08-01 00:00:00

  • Psoralen-induced DNA interstrand cross-links block transcription and induce p53 in an ataxia-telangiectasia and rad3-related-dependent manner.

    abstract::Psoralen plus UVA light (PUVA) is commonly used to treat psoriasis, a common skin disorder associated with rapid proliferation of cells. PUVA exerts its antiproliferative activity through formation of DNA monoadducts and interstrand cross-links (ICLs). However, this treatment may lead to skin malignancies as a direct ...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.108.051698

    authors: Derheimer FA,Hicks JK,Paulsen MT,Canman CE,Ljungman M

    更新日期:2009-03-01 00:00:00

  • Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system.

    abstract::Modulation of neuronal ion channels by the cloned rat brain CB1 cannabinoid receptor was investigated with the use of a heterologous neuronal expression system. Transient expression of the rat brain CB1 cannabinoid receptor was accomplished through microinjection of in vitro transcribed cRNA into the cytoplasm of enzy...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Pan X,Ikeda SR,Lewis DL

    更新日期:1996-04-01 00:00:00

  • Molecular interactions underlying the unusually high adenosine affinity of a novel Trypanosoma brucei nucleoside transporter.

    abstract::Trypanosoma brucei encodes a relatively high number of genes of the equilibrative nucleoside transporter (ENT) family. We report here the cloning and in-depth characterization of one T. brucei brucei ENT member, TbNT9/AT-D. This transporter was expressed in Saccharomyces cerevisiae and displayed a uniquely high affini...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.106.031559

    authors: Al-Salabi MI,Wallace LJ,Lüscher A,Mäser P,Candlish D,Rodenko B,Gould MK,Jabeen I,Ajith SN,de Koning HP

    更新日期:2007-03-01 00:00:00

  • Mutagenesis and modelling of the alpha(1b)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation.

    abstract::Computer simulations on a new model of the alpha1b-adrenergic receptor based on the crystal structure of rhodopsin have been combined with experimental mutagenesis to investigate the role of residues in the cytosolic half of helix 6 in receptor activation. Our results support the hypothesis that a salt bridge between ...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.61.5.1025

    authors: Greasley PJ,Fanelli F,Rossier O,Abuin L,Cotecchia S

    更新日期:2002-05-01 00:00:00

  • Effects of temperature and membrane phase transitions on ligand binding to alpha 2-receptors of human platelets.

    abstract::The binding of agonists and antagonists to alpha 2-adrenergic receptors of human platelets was studied. The receptors showed homogeneous affinities for antagonists but two affinity states for the agonist (-)-epinephrine, which were modulated by guanine nucleotides. Van't Hoff plots of antagonist binding had a break po...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Lohse MJ,Klotz KN,Schwabe U

    更新日期:1986-03-01 00:00:00

  • Identification of Peracetylated Quercetin as a Selective 12-Lipoxygenase Pathway Inhibitor in Human Platelets.

    abstract::The inflammatory response is necessary for the host's defense against pathogens; however, uncontrolled or unregulated production of eicosanoids has been associated with several types of chronic inflammatory diseases. Thus, it is not surprising that enzymes implicated in the production of eicosanoids have been strategi...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.118.113480

    authors: Doucet MS,Jougleux JL,Poirier SJ,Cormier M,Léger JL,Surette ME,Pichaud N,Touaibia M,Boudreau LH

    更新日期:2019-01-01 00:00:00

  • Regulation of pulmonary and hepatic cytochrome P4501A expression in the rat by hyperoxia: implications for hyperoxic lung injury.

    abstract::Supplemental oxygen therapy is frequently used in the treatment of pulmonary insufficiency, as is encountered in premature infants, and in patients with acute respiratory distress syndrome. However, hyperoxia causes lung damage in experimental animals and may do so in humans. Cytochrome P4501A enzymes have been implic...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.61.3.507

    authors: Couroucli XI,Welty SE,Geske RS,Moorthy B

    更新日期:2002-03-01 00:00:00

  • Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor Agonist.

    abstract::The Gαi/o-coupled dopamine D2-like receptor family comprises three subtypes: the D2 receptor (D2R), with short and long isoform variants (D2SR and D2LR), D3 receptor (D3R), and D4 receptor (D4R), with several polymorphic variants. The common overlap of norepinephrine innervation and D2-like receptor expression pattern...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.115.101808

    authors: Sánchez-Soto M,Bonifazi A,Cai NS,Ellenberger MP,Newman AH,Ferré S,Yano H

    更新日期:2016-04-01 00:00:00

  • Modified receptor internalization upon coexpression of 5-HT1B receptor and 5-HT2B receptors.

    abstract::Serotonin 5-HT(2B) receptors are often coexpressed with 5-HT(1B) receptors, and cross-talk between the two receptors has been reported in various cell types. However, many mechanistic details underlying 5-HT(1B) and 5-HT(2B) receptor cross-talk have not been elucidated. We hypothesized that 5-HT(2B) and 5-HT(1B) recep...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.106.032656

    authors: Janoshazi A,Deraet M,Callebert J,Setola V,Guenther S,Saubamea B,Manivet P,Launay JM,Maroteaux L

    更新日期:2007-06-01 00:00:00

  • Tricyclic antidepressants and dextromethorphan bind with higher affinity to the phencyclidine receptor in the absence of magnesium and L-glutamate.

    abstract::Recent studies from our laboratory have provided evidence that multiple states of the phencyclidine (PCP) receptor exist. In addition, several compounds such as PCP and the novel anticonvulsant MK-801 were found to inhibit binding more potently in the presence of Mg2+ and L-glutamate (L-GLU) than when these agents wer...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Sills MA,Loo PS

    更新日期:1989-07-01 00:00:00

  • Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms.

    abstract::We have identified four new mu-opiod receptor (MOR)-1 exons, indicating that the gene now contains at least nine exons spanning more than 200 kilobases. Replacement of exon 4 by combinations of the new exons yields three new receptors. When expressed in Chinese hamster ovary cells, all three variants displayed high af...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.56.2.396

    authors: Pan YX,Xu J,Bolan E,Abbadie C,Chang A,Zuckerman A,Rossi G,Pasternak GW

    更新日期:1999-08-01 00:00:00

  • Regulation of human monoamine oxidase B gene by Sp1 and Sp3.

    abstract::The human monoamine oxidase (MAO) B plays a major role in the degradation of biogenic and dietary amines such as phenylethylamine, benzylamine, dopamine, and tyramine. We previously showed that the -246/-99 MAO B promoter region exhibited the highest activity and contained two clusters of overlapping Sp1 sites, a CACC...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.59.4.852

    authors: Wong WK,Chen K,Shih JC

    更新日期:2001-04-01 00:00:00

  • A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning.

    abstract::Previous studies suggest that selective antagonists of specific subtypes of muscarinic acetylcholine receptors (mAChRs) may provide a novel approach for the treatment of certain central nervous system (CNS) disorders, including epileptic disorders, Parkinson's disease, and dystonia. Unfortunately, previously reported ...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.109.056531

    authors: Sheffler DJ,Williams R,Bridges TM,Xiang Z,Kane AS,Byun NE,Jadhav S,Mock MM,Zheng F,Lewis LM,Jones CK,Niswender CM,Weaver CD,Lindsley CW,Conn PJ

    更新日期:2009-08-01 00:00:00

  • The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.

    abstract::[3H]-d-cis-Diltiazem binds to canine cardiac sarcolemma in a specific, saturable, and reversible manner with a KD = 58.0 +/- 9.5 nM and a receptor site density (maximum binding) of 2.19 +/- 0.24 pmol/mg of protein. Bepridil and verapamil, Ca2+ channel inhibitors, can completely inhibit this binding at nM concentration...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Balwierczak JL,Johnson CL,Schwartz A

    更新日期:1987-02-01 00:00:00

  • Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.

    abstract::ATP-sensitive K(+) channels are closed by the hypoglycemic sulfonylureas like glibenclamide (GBC) and activated by a class of vasorelaxant compounds, the K(+) channel openers. These channels are octamers of Kir6.x and sulfonylurea receptor (SUR) subunits with 4:4 stoichiometry. The properties of the opener-sensitive K...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Russ U,Hambrock A,Artunc F,Löffler-Walz C,Horio Y,Kurachi Y,Quast U

    更新日期:1999-11-01 00:00:00

  • Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.

    abstract::The hexapeptide [pGlu6,Pro9]substance P (SP)6-11, septide, has been shown to be an agonist as potent as SP in eliciting smooth muscle contraction in several in vitro preparations, while being a poor competitor of labeled SP binding. These results, as well as other pharmacological data, have suggested the existence of ...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Pradier L,Ménager J,Le Guern J,Bock MD,Heuillet E,Fardin V,Garret C,Doble A,Mayaux JF

    更新日期:1994-02-01 00:00:00

  • The Anthracycline Metabolite Doxorubicinol Abolishes RyR2 Sensitivity to Physiological Changes in Luminal Ca2+ through an Interaction with Calsequestrin.

    abstract::The chemotherapeutic anthracycline metabolite doxorubicinol (doxOL) has been shown to interact with and disrupt the function of the cardiac ryanodine receptor Ca2+ release channel (RyR2) in the sarcoplasmic reticulum (SR) membrane and the SR Ca2+ binding protein calsequestrin 2 (CSQ2). Normal increases in RyR2 activit...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:10.1124/mol.117.108183

    authors: Hanna AD,Lam A,Thekkedam C,Willemse H,Dulhunty AF,Beard NA

    更新日期:2017-11-01 00:00:00

  • Selectivity for binding of peptide analogs to vascular receptors for vasoactive intestinal peptide.

    abstract::The structure-activity relationships for vasoactive intestinal peptide (VIP) receptor binding were studied using N-terminally modified VIP analogs. VIP fragments, and VIP receptor antagonists. Tissue sources included bovine coronary artery, rat mesenteric artery, rat pituitary, rat brain synaptosomes, and rat liver. E...

    journal_title:Molecular pharmacology

    pub_type: 杂志文章

    doi:

    authors: Rorstad OP,Wanke I,Coy DH,Fournier A,Huang M

    更新日期:1990-06-01 00:00:00